Back

New Therapies for Lipid management: PCSK9-I and Beyond.

4 December 2020 (18:55 - 19:05)
Organised by:
Congress Presentation Part of: Update on lipid management and new therapeutic options PCSK9 Risk Factors and Prevention ESC Premium Access ESC Asia with APSC & AFC 2020

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

2 More presentations in this session

Presentation thumbnail
Targets for lipid management: an Update.
Professor K. Tan (Hong Kong, HK)
Slides Video
Presentation thumbnail
Update on lipid management and new therapeutic options PCSK9.
Video

Access the full session

Session thumbnail
Update on lipid management and new therapeutic options PCSK9
Video

The Event

Event poster

ESC Asia with APSC & AFC 2020

4 December 2020 18:55 CET
You may be interested in
thumbnail
Congress Presentation
Targeting the PCSK9 pathway: where do novel therapies fit in?
26 August 2022
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study
18 April 2023
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources